About Synple Chem
Synple Chem is a company based in Zurich (Switzerland) founded in 2016 was acquired by eMolecules in September 2024.. Synple Chem has raised $10.2 thousand across 4 funding rounds from investors including European Union, eMolecules and Venture Kick. Synple Chem offers products and services including Synple 4.0, Synple 2, and Synple Reaction Kits. Synple Chem operates in a competitive market with competitors including Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, BioLife Solutions and RoosterBio, among others.
- Headquarter Zurich, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synple Chem Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.2 K (USD)
in 4 rounds
-
Latest Funding Round
$55.29 K (USD), Grant
Mar 31, 2020
-
Investors
European Union
& 3 more
-
Employee Count
Employee Count
-
Acquired by
eMolecules
(Sep 26, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synple Chem
Synple Chem offers a comprehensive portfolio of products and services, including Synple 4.0, Synple 2, and Synple Reaction Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for rapid virtual library hit synthesis in chemistry.
System for chemistry automation and reaction setups.
Kits enabling automated chemical reactions and experiments.
Funding Insights of Synple Chem
Synple Chem has successfully raised a total of $10.2K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $55.29 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $55,285
-
First Round
First Round
(01 Jun 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Grant - Synple Chem | Valuation |
investors |
|
| Oct, 2019 | Amount | Grant - Synple Chem | Valuation |
investors |
|
| Aug, 2018 | Amount | Grant - Synple Chem | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synple Chem
Synple Chem has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, eMolecules and Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synple Chem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synple Chem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synple Chem Comparisons
Competitors of Synple Chem
Synple Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, BioLife Solutions and RoosterBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| domain | founded_year | HQ Location |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synple Chem
Frequently Asked Questions about Synple Chem
When was Synple Chem founded?
Synple Chem was founded in 2016.
Where is Synple Chem located?
Synple Chem is headquartered in Zurich, Switzerland.
Is Synple Chem a funded company?
Synple Chem is a funded company, having raised a total of $10.2K across 4 funding rounds to date. The company's 1st funding round was a Grant of $58.32K, raised on Jun 01, 2016.
What does Synple Chem do?
Synple Chem was founded in 2016 in Zurich, Switzerland, and operates within the chemical synthesis sector. Automated synthesizers are produced by the company, utilizing reagent capsules to enable reactions for N-heterocycles. Structures such as morpholines, piperazines, oxazepanes, and diazepines are generated, along with spiro and bicyclic variants. Operations focus on facilitating complex organic compound assembly for research and development applications.
Who are the top competitors of Synple Chem?
Synple Chem's top competitors include Nuclera Nucleics, RoosterBio and BioLife Solutions.
What products or services does Synple Chem offer?
Synple Chem offers Synple 4.0, Synple 2, and Synple Reaction Kits.
Who are Synple Chem's investors?
Synple Chem has 4 investors. Key investors include European Union, eMolecules, Venture Kick, and EIC Fund.